S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
NYSEAMERICAN:BVX

Bovie Medical (BVX) Stock Price, News & Analysis

$6.48
+0.07 (+1.09%)
(As of 12/31/2018)
Today's Range
$6.35
$6.71
50-Day Range
N/A
52-Week Range
$2.28
$7.70
Volume
129,500 shs
Average Volume
136,878 shs
Market Capitalization
$215.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BVX stock logo

About Bovie Medical Stock (NYSEAMERICAN:BVX)

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

BVX Stock Price History

BVX Stock News Headlines

Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Bovie Medical earnings: here's what Wall Street expects
MEDICAL MYSTERIES
Bovie Medical (BVX) Looks Good: Stock Moves 9.1% Higher
See More Headlines
Receive BVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bovie Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2018
Today
4/16/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:BVX
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$215.14 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Charles D. Goodwin
    President, Chief Executive Officer & Director
  • Matthew C. Hill
    Chief Financial & Accounting Officer
  • Shawn D. Roman
    Director-Research & Development
  • Kari Larson
    Senior Director-Clinical Affairs
  • Todd Hornsby
    Executive Vice President

BVX Stock Analysis - Frequently Asked Questions

How were Bovie Medical's earnings last quarter?

Bovie Medical Co. (NYSEAMERICAN:BVX) released its quarterly earnings data on Thursday, November, 1st. The medical device company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.08. The medical device company earned $3.67 million during the quarter, compared to analysts' expectations of $3.67 million. The company's revenue for the quarter was up 38.5% compared to the same quarter last year. During the same period last year, the business earned ($0.09) earnings per share.

What other stocks do shareholders of Bovie Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bovie Medical investors own include Geron (GERN), AbbVie (ABBV), ENGlobal (ENG), Airgain (AIRG), Liquidity Services (LQDT), A.H. Belo (AHC), AMAG Pharmaceuticals (AMAG), Antares Pharma (ATRS), Ceragon Networks (CRNT) and Genetic Technologies (GENE).

How do I buy shares of Bovie Medical?

Shares of BVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:BVX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners